Hospital compounding to face shortage: A case study of the development of a lopinavir-ritonavir oral suspension during the first wave of SARS-COV-2 in France

por Secretan, P.-H., Thirion, O., Vieillard, V., Saunier, J., Razazi, K., Paul, M., Do, B.
Publicado 2022